Stay updated with breaking news from Surmodics Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surmodics (NASDAQ:SRDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday. SRDX has been the topic of a number of other reports. Sidoti restated a “neutral” rating and issued a $43.00 target price on shares of Surmodics in a report on Wednesday. […]
Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Sidoti in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $43.00 price objective on the stock. Sidoti’s price objective points to a potential upside of 2.09% from the company’s current price. Other equities […]
Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Lake Street Capital in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $43.00 target price on the stock. Lake Street Capital’s price target points to a potential upside of 2.14% from the company’s […]
Surmodics (NASDAQ:SRDX – Free Report) had its price objective lowered by Needham & Company LLC from $47.00 to $43.00 in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Separately, StockNews.com downgraded Surmodics from a strong-buy rating to a buy rating in a report on Wednesday, […]
Surmodics (NASDAQ:SRDX – Get Free Report) announced its earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.36) by $0.43, Zacks reports. The business had revenue of $31.96 million during the quarter, compared to analyst estimates of $28.79 million. Surmodics had a net margin […]